Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2 2024 Durable Medical Equipment Update

Skip to the end of the Expertise Menu

Q2 2024 Durable Medical Equipment Update

Market activity across the DME space continued at a steady pace throughout Q2 with a healthy mix of new platform developments and add-on acquisitions. High-growth product categories such as diabetic supplies continue to draw interest both from PE sponsors on a standalone basis and strategic consolidators seeking to diversify product offerings and capitalize on cross-sell opportunities within their existing patient populations.

Provident expects to see continued deal volume across DME throughout the remainder of 2024 as investors target organizations facilitating the shift towards home-based care, defensible market positioning, and an attractive growth profile. Several private equity platforms created in 2019 and 2020 are in the latter stages of their hold period and are likely to come to market within the next 6 – 12 months. This typically spurs additional add-on activity as new sponsors seek to deploy growth capital and take their new platform to the next level.

To print and download the full Durable Medical Equipment Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/07/Q2-2024-DME-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]